VERU

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Veru Inc

NASDAQ | VERU

2.45

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$39.16M

Market Cap

0.407

P/E Ratio

6

EPS

$14.20

52 Week High

$2.11

52 Week Low

HEALTHCARE

Sector

VERU Chart

Recent Chart
Price Action

VERU Technicals

Tags:

VERU Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $5.9M
Total Revenue $17M
Cost Of Revenue $11M
Costof Goods And Services Sold $11M
Operating Income -$37M
Selling General And Administrative $31M
Research And Development $13M
Operating Expenses $43M
Investment Income Net -
Net Interest Income -$607K
Interest Income -
Interest Expense $607K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $268K
Income Before Tax -$37M
Income Tax Expense $725K
Interest And Debt Expense -
Net Income From Continuing Operations -$38M
Comprehensive Income Net Of Tax -
Ebit -$36M
Ebitda -$36M
Net Income -$38M

Revenue & Profitability

Earnings Performance

VERU Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $60M
Total Current Assets $35M
Cash And Cash Equivalents At Carrying Value $25M
Cash And Short Term Investments $25M
Inventory $4.1M
Current Net Receivables $4M
Total Non Current Assets $25M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $6K
Intangible Assets Excluding Goodwill $6K
Goodwill $6.9M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2.2M
Other Non Current Assets -
Total Liabilities $28M
Total Current Liabilities $12M
Current Accounts Payable $3M
Deferred Revenue -
Current Debt -
Short Term Debt $2.1M
Total Non Current Liabilities $16M
Capital Lease Obligations $4M
Long Term Debt $8.9M
Current Long Term Debt $1M
Long Term Debt Noncurrent -
Short Long Term Debt Total $14M
Other Current Liabilities $6.3M
Other Non Current Liabilities $4.5M
Total Shareholder Equity $32M
Treasury Stock -
Retained Earnings -$295M
Common Stock $1.5M
Common Stock Shares Outstanding $13M

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$22M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $268K
Capital Expenditures $158K
Change In Receivables -
Change In Inventory $986K
Profit Loss -
Cashflow From Investment $146K
Cashflow From Financing $37M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$38M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $5.9M
Total Revenue $17M
Cost Of Revenue $11M
Costof Goods And Services Sold $11M
Operating Income -$37M
Selling General And Administrative $31M
Research And Development $13M
Operating Expenses $43M
Investment Income Net -
Net Interest Income -$607K
Interest Income -
Interest Expense $607K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $268K
Income Before Tax -$37M
Income Tax Expense $725K
Interest And Debt Expense -
Net Income From Continuing Operations -$38M
Comprehensive Income Net Of Tax -
Ebit -$36M
Ebitda -$36M
Net Income -$38M

Dividends

Field Value
Ex Dividend Date 2014-04-28
Declaration Date None
Record Date None
Payment Date None
Amount 0.07

VERU News

VERU Profile

Veru Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Veru Inc. is a clinical-stage biopharmaceutical company based in Miami, Florida, focused on developing innovative therapeutics primarily for oncology and unmet medical needs. The company's robust pipeline features a range of drug candidates designed to tackle various cancers, emphasizing both novel therapies and improvements to existing treatments. By leveraging its proprietary technologies and scientific acumen, Veru is dedicated to advancing patient care and delivering potentially life-saving solutions while enhancing shareholder value. With a commitment to addressing critical healthcare challenges, Veru positions itself at the forefront of biopharmaceutical innovation.

LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
TSLA
+1.71%
$426.58
CIFR
+9.30%
$19.15
KTTA
+74.52%
$1.85
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
DNN
+3.64%
$2.56
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
AMZN
-0.22%
$229.16
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
RIG
+6.17%
$4.30
RIVN
+3.98%
$16.18
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
BBD
+3.95%
$3.68
AGNC
+1.53%
$10.56
CETY
-11.20%
$2.06
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
BULL
+6.43%
$9.26
SNAP
-0.39%
$7.61
GOOG
-1.03%
$320.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
VALE
+2.62%
$12.51
ABEV
0.00%
$2.51
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
PLTD
-1.37%
$7.16
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ORCL
+4.02%
$204.96
UPWK
-0.55%
$19.58
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
PCG
+1.78%
$16.01
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
CMG
+1.88%
$34.03
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
MNDR
+39.47%
$2.65
SMCI
+1.07%
$32.83
QBTS
-0.79%
$22.41
BABA
+0.37%
$157.60
VSA
-14.30%
$0.12
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
MSTR
+2.00%
$175.64
SOUN
-1.00%
$11.82
LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
TSLA
+1.71%
$426.58
CIFR
+9.30%
$19.15
KTTA
+74.52%
$1.85
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
DNN
+3.64%
$2.56
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
AMZN
-0.22%
$229.16
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
RIG
+6.17%
$4.30
RIVN
+3.98%
$16.18
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
BBD
+3.95%
$3.68
AGNC
+1.53%
$10.56
CETY
-11.20%
$2.06
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
BULL
+6.43%
$9.26
SNAP
-0.39%
$7.61
GOOG
-1.03%
$320.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
VALE
+2.62%
$12.51
ABEV
0.00%
$2.51
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
PLTD
-1.37%
$7.16
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ORCL
+4.02%
$204.96
UPWK
-0.55%
$19.58
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
PCG
+1.78%
$16.01
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
CMG
+1.88%
$34.03
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
MNDR
+39.47%
$2.65
SMCI
+1.07%
$32.83
QBTS
-0.79%
$22.41
BABA
+0.37%
$157.60
VSA
-14.30%
$0.12
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
MSTR
+2.00%
$175.64
SOUN
-1.00%
$11.82
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.